The Philippine government signed a term sheet securing 40 million doses of Pfizer and BioNTech’s COVID-19 vaccine for the country, the health czar announced.
So far, the deal is the Philippines’ largest procurement of coronavirus vaccine.
All offers and conditions for the supply of vaccines are detailed in the term sheet. The document must be signed as the second-to-last step in the vaccine procurement process, followed by the signing of the final supply agreement with Pfizer to proceed with the actual purchase and secure specific delivery date.
Once finalized, it is expected to be funded by loans from international financial institutions like the World Bank and the Asian Development Bank.
“Vaccination really is our way out of all of this and the faster, the quicker, and the more coverage that we’re able to do, the faster we’ll be able to get out of this,” former Health Secretary Manuel Dayrit.
Following the Pfizer agreement, the country is set to finalize purchased deals with the Serum Institute of India for 30 million Novavax vaccine doses, 25 million Sinovac doses, 20 million Moderna and Gamaleya doses, 17 million AstraZeneca doses, and up to 10 million Johnson and Johnson (J&J) vaccine doses.
According to the latest data, around 1.86% of the country’s total population have been administered the first shot of the vaccine, and only 0.47% have taken both jabs.